An Update on Antimicrobial Peptides (AMPs) and Their Delivery Strategies for Wound Infections
Bacterial infections occur when wound healing fails to reach the final stage of healing, which is usually hindered by the presence of different pathogens. Different topical antimicrobial agents are used to inhibit bacterial growth due to antibiotic failure in reaching the infected site, which is acc...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/9/840 |
_version_ | 1827707010346385408 |
---|---|
author | Viorica Patrulea Gerrit Borchard Olivier Jordan |
author_facet | Viorica Patrulea Gerrit Borchard Olivier Jordan |
author_sort | Viorica Patrulea |
collection | DOAJ |
description | Bacterial infections occur when wound healing fails to reach the final stage of healing, which is usually hindered by the presence of different pathogens. Different topical antimicrobial agents are used to inhibit bacterial growth due to antibiotic failure in reaching the infected site, which is accompanied very often by increased drug resistance and other side effects. In this review, we focus on antimicrobial peptides (AMPs), especially those with a high potential of efficacy against multidrug-resistant and biofilm-forming bacteria and fungi present in wound infections. Currently, different AMPs undergo preclinical and clinical phase to combat infection-related diseases. AMP dendrimers (AMPDs) have been mentioned as potent microbial agents. Various AMP delivery strategies that are used to combat infection and modulate the healing rate—such as polymers, scaffolds, films and wound dressings, and organic and inorganic nanoparticles—have been discussed as well. New technologies such as Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-associated protein (CRISPR-Cas) are taken into consideration as potential future tools for AMP delivery in skin therapy. |
first_indexed | 2024-03-10T16:37:37Z |
format | Article |
id | doaj.art-369cad3550bf4e6e93de04bd4ea512bc |
institution | Directory Open Access Journal |
issn | 1999-4923 |
language | English |
last_indexed | 2024-03-10T16:37:37Z |
publishDate | 2020-09-01 |
publisher | MDPI AG |
record_format | Article |
series | Pharmaceutics |
spelling | doaj.art-369cad3550bf4e6e93de04bd4ea512bc2023-11-20T12:17:58ZengMDPI AGPharmaceutics1999-49232020-09-0112984010.3390/pharmaceutics12090840An Update on Antimicrobial Peptides (AMPs) and Their Delivery Strategies for Wound InfectionsViorica Patrulea0Gerrit Borchard1Olivier Jordan2Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, 1 Rue Michel Servet, 1211 Geneva, SwitzerlandInstitute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, 1 Rue Michel Servet, 1211 Geneva, SwitzerlandInstitute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, 1 Rue Michel Servet, 1211 Geneva, SwitzerlandBacterial infections occur when wound healing fails to reach the final stage of healing, which is usually hindered by the presence of different pathogens. Different topical antimicrobial agents are used to inhibit bacterial growth due to antibiotic failure in reaching the infected site, which is accompanied very often by increased drug resistance and other side effects. In this review, we focus on antimicrobial peptides (AMPs), especially those with a high potential of efficacy against multidrug-resistant and biofilm-forming bacteria and fungi present in wound infections. Currently, different AMPs undergo preclinical and clinical phase to combat infection-related diseases. AMP dendrimers (AMPDs) have been mentioned as potent microbial agents. Various AMP delivery strategies that are used to combat infection and modulate the healing rate—such as polymers, scaffolds, films and wound dressings, and organic and inorganic nanoparticles—have been discussed as well. New technologies such as Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-associated protein (CRISPR-Cas) are taken into consideration as potential future tools for AMP delivery in skin therapy.https://www.mdpi.com/1999-4923/12/9/840bacterial infectionnon-healing woundsantimicrobial resistancemultidrug resistanceantimicrobial peptides (AMPs)AMP conjugates |
spellingShingle | Viorica Patrulea Gerrit Borchard Olivier Jordan An Update on Antimicrobial Peptides (AMPs) and Their Delivery Strategies for Wound Infections Pharmaceutics bacterial infection non-healing wounds antimicrobial resistance multidrug resistance antimicrobial peptides (AMPs) AMP conjugates |
title | An Update on Antimicrobial Peptides (AMPs) and Their Delivery Strategies for Wound Infections |
title_full | An Update on Antimicrobial Peptides (AMPs) and Their Delivery Strategies for Wound Infections |
title_fullStr | An Update on Antimicrobial Peptides (AMPs) and Their Delivery Strategies for Wound Infections |
title_full_unstemmed | An Update on Antimicrobial Peptides (AMPs) and Their Delivery Strategies for Wound Infections |
title_short | An Update on Antimicrobial Peptides (AMPs) and Their Delivery Strategies for Wound Infections |
title_sort | update on antimicrobial peptides amps and their delivery strategies for wound infections |
topic | bacterial infection non-healing wounds antimicrobial resistance multidrug resistance antimicrobial peptides (AMPs) AMP conjugates |
url | https://www.mdpi.com/1999-4923/12/9/840 |
work_keys_str_mv | AT vioricapatrulea anupdateonantimicrobialpeptidesampsandtheirdeliverystrategiesforwoundinfections AT gerritborchard anupdateonantimicrobialpeptidesampsandtheirdeliverystrategiesforwoundinfections AT olivierjordan anupdateonantimicrobialpeptidesampsandtheirdeliverystrategiesforwoundinfections AT vioricapatrulea updateonantimicrobialpeptidesampsandtheirdeliverystrategiesforwoundinfections AT gerritborchard updateonantimicrobialpeptidesampsandtheirdeliverystrategiesforwoundinfections AT olivierjordan updateonantimicrobialpeptidesampsandtheirdeliverystrategiesforwoundinfections |